• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR P14; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR P14; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515100
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/04/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported while using bd phaseal¿ protector p14 leakage occurred.There was no report of patient impact.The following information was provided by the initial reporter, translated from french to english: after attaching the second vial to the protector, the ide turned the system horizontal to inject air into the second vial.At this point, the ide noticed a leak of the product between the vial and the protector.The nurse recovered the prescribed amount of product.
 
Additional Manufacturer Narrative
Medical device lot #: 10301 was reported, however, this is not a lot # manufactured for the reported catalog #.Medical device expiration date: unknown.Device manufacture date: unknown.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: 05-dec-2022.H6: investigation summary: one protector connected to a vial was provided to our quality team for investigation.Functional testing was performed, and no leakage between the protector and vial was observed.Further evaluation identified the protector needle penetrated the vial off center and staining was observed on the vial stopper, indicating a leak may have occurred during use of the product.Product undergoes visual and functional evaluations throughout the manufacturing process, including leakage testing and verification all critical dimensions are within specification.As a valid lot was not provided, a device history review could not be performed.Based on the available information we are not able to identify a root cause related to the manufacturing process at this time.This incident was likely a result of the protector being improperly attached, causing the needle to penetrate off center.The protector must be attached completely vertical to the vial.
 
Event or Problem Description
It was reported while using bd phaseal¿ protector p14 leakage occurred.There was no report of patient impact.The following information was provided by the initial reporter, translated from french to english: after attaching the second vial to the protector, the ide turned the system horizontal to inject air into the second vial.At this point, the ide noticed a leak of the product between the vial and the protector.The nurse recovered the prescribed amount of product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ PROTECTOR P14
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15789556
Report Number3003152976-2022-00510
Device Sequence Number12168091
Product Code ONB
UDI-Device Identifier00382905151002
UDI-Public00382905151002
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K123213
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number515100
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/19/2022
Supplement Date Received by Manufacturer01/23/2023
Initial Report FDA Received Date11/14/2022
Supplement Report FDA Received Date02/07/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-